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ABSTRACT
Density gradient centrifugation can separate motile sperm from immotile sperm and other cells
for assisted reproduction, but may also remove antioxidants from seminal plasma, resulting in
oxidative stress. Therefore, we investigated reactive oxygen species (ROS) concentrations and
distribution in semen before and after density gradient centrifugation. We assessed semen
volume, sperm concentration, sperm motility, and ROS levels before and after density gradient
centrifugation (300 x g for 20 minutes) in 143 semen samples from 118 patients. The ROS removal
rate was evaluated in ROS-positive samples and ROS formation rate in ROS-negative samples.
Thirty-eight of 143 untreated samples (26.6%) were ROS-positive; sperm motility was significantly
lower in these samples than in ROS-negative samples (p < 0.05). After density gradient centrifuga-
tion, only seven of the 38 ROS-positive samples (18.42%) exhibited a ROS-positive lower layer
(containing motile sperm) with a ROS removal rate of 81.58%, whereas the upper layer was ROS-
positive in 24 samples (63.16%). In the ROS-negative group (n = 105), ROS was detected in 19
samples after centrifugation (18.10%, ROS generation rate), of which 18 were ROS-positive only in
the upper layer or interface and the other was ROS-positive in both layers. Density gradient
centrifugation can separate motile sperm from immotile sperm as well as remove ROS (including
newly generated ROS). This data supports the view that density gradient centrifugation can select
motile spermatozoa without enhancing oxidative stress.
Abbreviations: ROS: reactive oxygen species; SOD: superoxide dismutase; GPx: glutathione
peroxidase; DNA: deoxyribonucleic acid; DGC: density gradient centrifugation; IUI: intrauterine
insemination; IVF: in vitro fertilization; HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
EDTA: ethylenediaminetetraacetic acid; HTF: HEPES-buffered human tubal fluid; IMSI: intracyto-
plasmic morphologically selected sperm injection; SMAS: sperm motility analyzing system; CASA:
computer-assisted semen analyzer; WHO: World Health Organization
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Infertility is defined as the inability to achieve pregnancy
after one year of regular, unprotected, and well-timed
intercourse [Practice Committee of American Society for
Reproductive Medicine 2013]. Approximately half of all
cases presenting at infertility clinics are because of male
factors [Sabanegh and Agarwal 2012]. The etiology of male
infertility is multifactorial and most cases are idiopathic
[Sabanegh and Agarwal 2012]. Oxidative stress may be a
critical factor in male fertility [Aitken and Clarkson 1987;
Tremellen 2008; Agarwal et al. 1994]. Reactive oxygen
species (ROS), such as hydrogen peroxide (H2O2), super-
oxide anion. (O2
−), and hydroxyl radicals. (OH), are pro-
duced via aerobic metabolism [Holland et al. 1982]. At low
levels, ROS functions as essential second messengers in
fertilization processes, including capacitation, hyperactiva-
tion, the acrosome reaction, and sperm–oocyte fusion
[Sharma and Agarwal 1996; Aitken 1997; Agarwal et al.
2004]. Seminal plasma contains abundant enzymatic anti-
oxidants, such as superoxide dismutase (SOD), glutathione
peroxidase (GPx), and catalase as well as nonenzymatic
antioxidants, such as ascorbic acid, tocopherol, and coen-
zyme Q10 [Lewis et al. 1997; Pahune et al. 2013]. Oxidative
stress results from the imbalance between ROS production
and antioxidant capacity [Sharma and Agarwal 1996].
Excessive ROS generation in semen has been observed in
approximately 30–40% of infertile men [Iwasaki and
Gagnon 1992] and is known to impair sperm mitochon-
drial respiration and damage deoxyribonucleic nucleic acid
(DNA) [Aitken et al. 1998; Kodama et al. 1997; Sawyer
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2003; Santiso et al. 2010]. Elevated ROS production also
causes peroxidation of membrane polyunsaturated fatty
acids, particularly docosahexanoic acid, which has six dou-
ble bonds per molecule [Jones et al. 1979]. This lipid
peroxidation results in loss of sperm motility and mem-
brane fluidity, which impairs fusion with the vitelline
membrane of the oocyte. The principal sources of endo-
genous ROS in semen are leukocytes [Aitken and Clarkson
1987; Aitken and Clarkson 1988; Sharma 2001] and imma-
ture spermatozoa with abnormal head morphology and
cytoplasmic retention [Gomez 1996; Sakkas 2003;
Koppers et al. 2010]. Therefore, removing seminal leuko-
cytes and immature spermatozoa from semen may
improve sperm motility and help maintain membrane
and chromatin integrity, ultimately improving male
fertility.
Discontinuous density gradient centrifugation (DGC)
techniques have been used extensively prior to intrauter-
ine insemination (IUI) and in vitro fertilization (IVF) to
separate motile spermatozoa from immotile spermatozoa
and other cells (leukocytes, epithelial cells, and bacteria),
and to eliminate toxic substances like decapacitation fac-
tor, prostaglandin, and ROS [Henkel and Schill 2003].
Generally, a motile mature spermatozoon has a higher
density (1.10 g/mL) than an immotile (1.06 g/mL) or
immature spermatozoon (1.09 g/mL) [Oshio et al.
1987]. After centrifugation, leukocytes and cell debris
are concentrated in the interface between the seminal
plasma and upper layer, and morphologically abnormal
spermatozoa collect in the interface between the upper
and lower layer, while motile and mature spermatozoa
form a pellet at the bottom of the tube [Malvezzi et al.
2014]. However, the antioxidants contained in seminal
plasma are also removed, increasing net ROS production
by spermatozoa and leukocytes [Iwasaki and Gagnon
1992]. Thus, shearing forces during DGC may lead to
ROS production and oxidative stress in motile sperm
[Aitken and Clarkson 1988]. In the present study, we
evaluated how ROS affects sperm motility and the dis-
tribution of ROS among layers following DGC.
Results
Of the 143 semen samples collected, 38 (26.6%) were ROS-
positive. The ROS level of the sample was defined as the
integrated chemiluminescence between 0 and 30 min after
the addition of luminol (in mV/30 min/108 spermatozoa)
(Figure 1). These ROS-positive samples did not differ from
ROS-negative samples in either volume (3.72 ± 0.19 ml vs.
3.32 ± 0.30 ml) or sperm concentration (25.89 ± 2.59 ×106/
ml vs. 30.20 ± 4.54 ×106/ml), but showed significantly
lower sperm motility (18.15 ± 1.75% vs. 12.96 ± 1.60%, p
< 0.05) (Table 1). The logarithmically transformed ROS
level exhibited a strong negative correlation with sperm
motility (p < 0.05, r = −0.37) (Figure 2). Following centri-
fugation, the sperm concentration was significantly lower
in the bottom layer and pellet (Figure 3, Layer 2) than in
the top layer and interface (Layer 1), both for the entire
sample set (4.97 ± 0.61 ×106/ml vs. 14.20 ± 1.50 ×106/ml; p
< 0.01) and in ROS-positive and ROS-negative groups
(Table 2). However, the proportion of motile sperm was
significantly higher in Layer 2 than in Layer 1, for both
sample sets (16.10% ± 1.71% vs. 11.61% ± 1.15%; p < 0.01)
and in ROS-positive and -negative groups (Table 2). Of the
38 samples deemed ROS-positive before centrifugation,
only seven (18.42%) were ROS-positive in Layer 2 after
centrifugation (for a ROS removal rate of 81.56%), whereas
24 samples were ROS-positive in Layer 1. Of the seven
Figure 1. Measurement of ROS by chemiluminescence
method. Reactive oxygen species (ROS) production in the
present study was calculated as the integrated chemilumines-
cence between 0 and 30 minutes after the addition of luminol
(5-amino-2,3-dihydro-1,4-phtalazine-dione) to unwashed
semen after baseline subtraction (expressed as mV/s/30 min/
108 spermatozoa) (A).
Table 1. Semen parameters of reactive oxygen species (ROS)-positive and -negative groups.
Overall (n = 143) ROS-negative (n = 105) ROS-positive (n = 38) P value
Agea 35 (20 - 55) 35 (20 - 51) 35 (25 - 55) 0.1396
Semen volume (ml)b 3.61 ± 0.16 3.72 ± 0.19 3.32 ± 0.30 0.1300
Sperm concentration (million/ml)b 27.03 ± 2.25 25.89 ± 2.59 30.20 ± 4.54 0.1997
Sperm motility (%)b 16.77 ± 1.36 18.15 ± 1.75 12.96 ± 1.60 0.0468
aData are shown median (range).
bData are shown mean ± standard error (SE) for continuous variables.
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samples positive for ROS in Layer 2, five were also positive
in Layer 1, and the ROS levels in Layer 2 were lower than
that in Layer 1 (Table 2). After DGC, the ROS level was
significantly elevated in Layer 1 compared with that in
unwashed semen (1146.01 ± 955.77 vs. 205.59 ± 164.21
mV/30 min/108 spermatozoa, p < 0.01), but significantly
lower in Layer 2 (157.16 ± 109.91 vs. 205.59 ± 164.21 mV/
30 min/108 spermatozoa, p < 0.01). In the ROS-negative
group (n = 105), 19 samples were ROS-positive after cen-
trifugation (18.10%), of which 17 were positive in only
Layer 1 and two samples were positive in both layers.
Discussion
Elevated ROS levels in semen are associated with the loss of
sperm motility and membrane fluidity, leading to a lower
fertilization rate [Das et al. 2008; Zorn et al. 2003] and
higher risk of miscarriage [Khosrowbeygi and Zarghami
2007]. Therefore, the semen ROS level is an important
factor influencing the success rates of assisted reproductive
technologies. Reproductive success is also enhanced by
selection of motile sperm by centrifugation, but it was
unclear how centrifugation affected ROS levels. DGC can
separate motile spermatozoa from leukocytes and imma-
ture spermatozoa, which are sources of ROS. We demon-
strated that the lower layer enriched in motile sperm
actually exhibits lower ROS levels than unwashed samples,
indicating that separation is not accompanied by oxidative
stress.
n contrast to DGC, ROS cannot be separated by the
conventional swim-up technique because motile sperm
can maintain close cell-to-cell contact with leukocytes, cell
debris, and immature spermatozoa [Ford 1990]. Moreover,
Enciso et al. [2011] reported that the DGC using
SpermGrad™ and the swim-up technique were equally
effective in eliminating spermatozoa containing double-
strand DNA damage, while DGC was more effective in
eliminating single-strand DNA damage than the swim-up
technique.
In the present study, DGC using SpermGrad™ as the
sperm-washing medium effectively separated motile from
immotile spermatozoa. Furthermore, the lower layer
post-centrifugation (Layer 2) enriched in motile sperma-
tozoa had a low positive rate (6.29%), particularly in the
absence of a ROS-positive upper layer. Conversely, the
upper layer post-centrifugation (Layer 1), containing
immotile spermatozoa and cell debris had a relatively
high positive rate (30.07%) of ROS. In particular, in the
ROS-positive group, the removal rate of ROS in the lower
layer post-centrifugation was as high as 81.57%, whereas
ROS in the upper layer was 63.16%. In those cases, in
Figure 2. Correlation between ROS levels and sperm motility in
the ROS-positive group. Scatterplot of logarithmic transformed
reactive oxygen species (ROS) levels showing a strong negative
correlation with sperm motility as measured by sperm motility
analyzing system (SMAS) in the ROS-positive group (r = −0.37,
p < 0.05).
Figure 3. Schematics of sperm preparation by density gradient separation. One microliter of liquefied semen sample was loaded
onto a 45% and 90% discontinuous gradient (each 1.0 mL) and centrifuged at 300 g for 20 minutes at room temperature. Then, 0.55
ml of Layer 1 (including the interface between upper and lower layers) and the same volume of Layer 2 (including the pellet) were
extracted. For each sample, conventional semen analyses and chemiluminescence ROS measurements were performed.
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which ROS was not detected in either layer, ROS may
have pooled in the interface between seminal plasma and
the upper layer. Therefore, the ROS detected in unwashed
semen was separated from the lower layer after centrifu-
gation, likely by removal of ROS sources (leukocytes and
immature spermatozoa), and ROS was not generated in
substantial amounts within the lower layer.
In contrast to our results, Iwasaki and Gagnon [1992]
reported that Percoll-washed spermatozoa produced 4–5
fold more ROS than the original semen sample. One pos-
sible cause of this increase is that Percoll has been diluted
with a buffer not containing antioxidants, whereas seminal
plasma containing antioxidants, such as superoxide dismu-
tase, catalase, and glutathione peroxidase, were removed
[Iwasaki and Gagnon 1992]. Another possible explanation
is that some of the abnormal spermatozoa generating ROS
had no gross morphological defects and were present in
samples with normal sperm density [Iwasaki and Gagnon
1992]. Therefore, antioxidants are supplied in a HEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid)-buf-
fered solution with EDTA (ethylenediaminetetraacetic
acid) as a divalent cation chelator. SpermGrad™ is stabilized
with bicarbonate and HEPES buffered medium containing
silane-coated, colloid silica particles. SpermRinse™, which
was used to dilute SpermGrad™ contains EDTA.
PureCeption™ and Isolate™ are other commercially avail-
able density gradient media, both consisting of a colloidal
suspension of silica particles stabilized with covalently
bound hydrophilic silane in HEPES-buffered human
tubal fluid (HTF). No significant increases in sperm DNA
damage were observed in the lower layer after DGC using
these media [Malvezzi et al. 2014]. Therefore, a similar
outcome was expected using these media in our study.
In comparison, Aitken et al. reported oxidative DNA
damage in spermatozoa prepared using PureSperm™ dis-
continuous colloidal silicon gradient because of the pre-
sence of metals, such as Fe and Cu, which are known to
promote oxidative DNA damage and strand breakage
[Aitken et al. 2014]. Compared with PureSperm™,
SpermGrad™ contains lower levels of Fe (38.293 ± 7.276
mg/L vs. 8.850 ± 0.277 mg/L) and other metals.
Therefore, although the generation rate of ROS in the
lower layer post-centrifugation was 18.10% in the ROS-
negative group, most were detected in the upper layer
and rarely detected in the lower layer. The reduced ROS
in the lower layer relative to the unwashed samples
strongly suggests that the treatment of semen by DGC
does not expose motile sperm to oxidative stress. Several
studies have reported that excessive ROS levels in
washed semen are negatively correlated with fertilization
and pregnancy rates [Zorn et al. 2003; Das et al. 2008;
Ahelik et al. 2015]. Furthermore, ROS levels were higher
in unwashed semen samples of couples that did not
achieve pregnancy compared to those that did
[Yumura et al. 2009]. Thus, we suggest that centrifuga-
tion under described conditions may serve to enhance
IUI or IVF success by reducing oxidative stress in sper-
matozoa. However, as we have not yet assessed the
fertilization and pregnancy rates of our subjects, this
requires confirmation in future studies. Other reported
approaches of sperm selection that overcome production
of oxidative stress and remove sperm with DNA damage
include electrophoretic separation, surgical sperm retrie-
val, and intracytoplasmic morphologically selected
sperm injection (IMSI) [Sakkas 2013]. The efficacy of
these techniques on reducing oxidative stress needs to be
validated in future studies.
Conclusions
DGC can separate motile spermatozoa from immotile
spermatozoa, leukocytes, cell debris, and toxic ROS prior
to assisted reproductive treatments. Thus, DGC is
recommended to improve the success of IUI and IVF.
Table 2. Sperm concentration, sperm motility, number of ROS positive samples, and ROS level between unwashed semen, upper
layer (Layer 1), lower layer (Layer 2) after density gradient centrifugation in ROS-positive and negative group.
unwashed
After DGC
P valueLayer 1 Layer 2
ROS-positive group (n = 38) Sperm concentration (million/ml)a 30.20 ± 4.54 14.68 ± 2.50 4.30 ± 0.97 < 0.0001
Sperm motility (%)a 12.96 ± 1.60 10.90 ± 2.29 16.17 ± 3.15 < 0.0001
Number of ROS positive samples 38 24 7
ROS level (mv/30 min/108 spermatozoa)a 205.59 ± 164.21 1146.01 ± 955.77 157.16 ± 109.91 < 0.0001
ROS-negative group (n = 105) Sperm concentration (million/ml)a 25.89 ± 2.59 14.03 ± 1.84 5.20 ± 0.75 < 0.0001
Sperm motility (%)a 18.15 ± 1.75 11.86 ± 1.34 16.07 ± 2.04 < 0.0001
Number of ROS positive samples 0 19 2
ROS level (mv/30 min/108 spermatozoa)a 0 12.87 ± 8.75 0.13 ± 0.13 < 0.0001
ROS: reactive oxygen species; DGC: density gradient centrifugation.
aData are shown mean ± standard error (SE) for continuous variables.
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Material and methods
Subjects
We examined 143 semen samples from 118 patients
(mean age, 35 years; range, 20–55 years) consulting
our male infertility clinic at the Reproductive Center,
Yokohama City University Medical Center, from June
2011 to February 2012. Azoospermic patients were
excluded. Every patient received a medical interview,
medical examination, and endocrine examination at the
first consultation. All patients provided informed con-
sent for participation. The study design was approved
by the Institutional Review Board of Yokohama City
University Medical Center.
Semen collection and assessment of semen
parameters
Semen specimens were collected by masturbation after
48–120 h of sexual abstinence. Semen analyses were
conducted using the sperm motility analyzing system
(SMAS™: DITECT Ltd, Tokyo, Japan), a computer-
assisted semen analyzer (CASA) consisting of a digital
scanning camera, personal computer with a digital
frame grabber, image processing software, and compu-
ter monitor, at 37°C after complete liquefaction
[Komori et al. 2006; Akashi et al. 2010]. Semen volume
(ml), sperm concentration (×106/ml), and sperm moti-
lity (%) were measured in accordance with the criteria
of the World Health Organization [WHO, 2010] stan-
dards. However, sperm morphology could not be eval-
uated by SMAS.
ROS measurement
The ROS formation level in unwashed semen samples
was measured using a computer-driven LKB Wallac
1251 Luminometer™ (LKB-Wallac, Turku, Finland)
simultaneous with the routine semen analysis. Briefly,
chemiluminescence was recorded adding 40 μl of 100
mM luminol (5-amino-2,3-dihydro 1,4-phtalazine-
dione) to 500 μl of unwashed semen. Samples were
considered positive for ROS production if peak lumi-
nescence was ≥ 0.1 mV/s [Iwasaki and Gagnon 1992;
Takeshima et al. 2016]. The ROS level of the sample
was defined as the integrated chemiluminescence
between 0 and 30 min after the addition of luminol
(in mV/30 min/108 spermatozoa) (Figure 1). We
divided semen samples into ROS-positive and ROS-
negative groups. When ROS formation was negative,
we expressed the ROS level as zero.
Density gradient centrifugation
Discontinuous density gradients were prepared by
sequentially adding 1 ml of 90% and 1 ml of 45%
SpermGrad™ (Vitrolife, Gothenburg, Sweden) diluted
in SpermRinse™ (Vitrolife) to test tubes. Using a new
sterile pipette, 1 ml of the ejaculate was placed on the
upper layer before centrifugation at 300 g for 20 min at
room temperature. After centrifugation, seminal
plasma was removed, and 0.55 ml samples of Layer 1
(including the interface between upper and lower
layers) and the same volume of Layer 2 (including the
pellet) were extracted (Figure 3). Conventional semen
analyses (performed with SMAS™) and chemilumines-
cence ROS measurements were conducted for each
sample as soon as DGC was finished. The removal
rate in the ROS-positive group and the generation
rate in the ROS-negative group were evaluated as
follows.
removal rate of ROS
¼ number of ROS-positive samples in Layer2
number of ROS-positive samples in unwashed semen
" 100ð%Þ
generation rate of ROS
¼ number of ROS-positive samples in either layer
number of ROS-negative samples in unwashed semen
" 100ð%Þ
Statistical analysis
Statistical analysis was performed using StatMate V™
(ATMS Co., Ltd., Tokyo, Japan). All data are reported as
mean ± standard error (SE). Group differences (ROS-
negative and -positive groups) were evaluated by unpaired
t-test (parametric variant). Correlations between semen
parameters and ROS levels (normalized by logarithmic
transformation because of the skewed distribution in the
ROS-positive group) were evaluated by Pearson’s correla-
tion coefficient. Layer-specific semen parameters were
compared within groups by the Wilcoxon signed rank
test (nonparametric variant). ROS levels in unwashed
semen and each layer post-centrifugation were compared
by Friedman test (nonparametric variant). A p value < 0.05
was considered statistically significant in all cases.
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